What is the recommended management of primary nocturnal enuresis in a healthy child aged five years or older?

Management of Primary Nocturnal Enuresis in Children ≥5 Years

For a healthy child aged five years or older with primary nocturnal enuresis, begin with proper evaluation (history, voiding chart, urinalysis) followed by first-line treatment with either an enuresis alarm or desmopressin, selected based on the child's voiding pattern—use desmopressin for nocturnal polyuria with normal bladder capacity, and use the alarm for reduced bladder capacity without polyuria. 1, 2

Initial Evaluation

Essential Components

• Complete a frequency-volume chart for at least 1 week (ideally 2 days with intake/output) to differentiate nocturnal polyuria from reduced bladder capacity—this is the single most important diagnostic tool and should never be omitted 2
• Perform urinalysis to rule out diabetes mellitus, urinary tract infection, or kidney disease 1, 2
• Take a thorough history focusing on:
  • Daytime voiding symptoms (urgency, frequency, incontinence) to distinguish monosymptomatic from non-monosymptomatic enuresis 3
  • Constipation or fecal impaction (treating constipation resolves enuresis in up to 63% of cases) 2
  • Sleep-disordered breathing or obstructive sleep apnea 3
  • Family history and psychosocial stressors 3

Key Diagnostic Thresholds from Voiding Chart

• Nocturnal polyuria: nighttime urine production >130% of expected bladder capacity for age 4
• Normal bladder capacity: maximum voided volume >70% of expected bladder capacity for age 4

Behavioral Interventions (Foundation for All Cases)

Implement these measures before or alongside any specific therapy:

• Establish regular daytime voiding schedules: morning, at least twice during school, after school, dinner time, and bedtime 2
• Minimize evening fluid intake (limit to ≤200 ml or 6 ounces) while encouraging liberal water intake during morning and early afternoon 2, 4
• Avoid caffeinated beverages 2
• Treat constipation aggressively with polyethylene glycol if present—aim for soft daily bowel movements, preferably after breakfast 2, 4
• Implement a reward system (sticker chart) for dry nights to increase motivation 2
• Involve the child in changing wet bedding to raise awareness (not as punishment) 2
• Educate families that bedwetting affects 15-20% of 5-year-olds with 14% spontaneous annual remission rate to reduce parental guilt 2
• Never punish, shame, or create control struggles—this worsens the condition and creates psychological distress 2, 3

First-Line Treatment Selection Algorithm

For Children with Nocturnal Polyuria + Normal Bladder Capacity

Prescribe desmopressin:

• Dosing: 0.2-0.4 mg tablets OR 120-240 mcg melt formulation, taken 1 hour before bedtime 2, 4
• Strict fluid restriction is mandatory: ≤200 ml (6 ounces) evening intake with no drinking until morning to prevent hyponatremia 2, 4
• Polydipsia is an absolute contraindication 4
• Avoid nasal spray formulations due to higher hyponatremia risk 4
• Expected response: approximately 30% full response and 40% partial response 2, 4
• Immediate anti-enuretic effect occurs 2
• Schedule regular drug holidays to assess ongoing need 4

Critical Safety Warning: Desmopressin combined with excessive fluid intake can cause water intoxication with hyponatremia and convulsions 4

For Children with Low Voided Volume (Reduced Bladder Capacity) Without Polyuria

Prescribe enuresis alarm therapy:

• Success rate approximately 66%, with more than half achieving long-term success 3
• Essential components for success 2, 3:
  • Provide written instructions
  • Establish a treatment contract with the family
  • Schedule frequent monitoring appointments (monthly follow-up sustains motivation) 2
  • Expect treatment duration of at least 2-3 months before attempting to wean 2
  • Use overlearning techniques and intermittent reinforcement before discontinuation 3
• Preferred for motivated families and children without nocturnal polyuria 2

Second-Line and Combination Therapies

When First-Line Therapy Fails After 1-2 Months

• Switch to the alternative first-line option (alarm to desmopressin or vice versa) 2, 3
• Consider combination therapy (alarm + desmopressin) for resistant cases 2, 3
• Re-evaluate for missed comorbidities: constipation, sleep-disordered breathing, overactive bladder 2

Anticholinergic Agents (Second-Line)

Consider only when detrusor overactivity is suspected:

• Options: oxybutynin 5 mg, tolterodine 2 mg, or propiverine 0.4 mg/kg at bedtime 2
• Monitor for constipation and post-void residual urine that may cause UTIs 2
• Not indicated for typical monosymptomatic enuresis unless overactive bladder is present 5

Imipramine (Third-Line Only)

Reserve for therapy-resistant cases at tertiary care facilities due to safety concerns:

• Approximately 50% response rate in therapy-resistant enuresis 2
• FDA dosing for childhood enuresis 6:
  • Initial: 25 mg/day one hour before bedtime for children ≥6 years
  • If no response in one week: increase to 50 mg nightly (children <12 years) or 75 mg nightly (children >12 years)
  • Maximum: 75 mg/day (do not exceed 2.5 mg/kg/day)
  • For early-night bedwetters: 25 mg mid-afternoon, repeated at bedtime
• Taper gradually rather than abrupt discontinuation 6
• ECG changes of unknown significance reported at doses >2.5 mg/kg/day 6

Common Pitfalls to Avoid

• Never omit the frequency-volume chart—it is critical for individualizing therapy and predicting treatment response 2
• Do not assume primary nocturnal enuresis is a toilet-training problem—by age 6, daytime training should be established; nocturnal control requires specific interventions 2
• Do not prescribe desmopressin without strict fluid restriction counseling—this is the most dangerous error 4
• Do not expect immediate success with alarm therapy—families need realistic expectations of 2-3 months minimum 2
• Do not overlook constipation—treat it first before escalating urinary treatments 2
• Reassess diagnosis if no improvement after 1-2 months of consistent therapy and consider specialist referral 2

When to Refer to Pediatric Urology

• Primary enuresis refractory to standard and combination therapies 7
• Daytime wetting, abnormal voiding patterns, or history of recurrent UTIs 3
• Suspected urinary tract malformations or neurologic disorders 3, 7
• Genital abnormalities on examination 3